Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung

Allen TM (2002) Ligand targeted therapeutic in anticancer therapy. Nat Rev 2:263

Alpiaz A, Mezzena M, Scatturin A, Scalia S (2008) Solid lipid microparticles for the stability enhancement of the polar drug N-6-cyclopentyladenosine. Int J Pharm 355(1–2):81–86

Anisimova YV, Gelperina SI, Peloquin CA, Heifets LB (2000) Nanoparticles as antituberculosis drugs carriers: effect on activity against Mycobacterium tuberculosis in human monocyte-derived macrophages. J Nanopart Res 2:165–171

Baek JS, Cho CW (2013) 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells. J Pharm Pharmacol 65(1):72–78

Calleja I, Blanco-Prieto MJ, Ruz N, Renedo MJ, Dios-Vieitez MC (2004) High-performance liquid-chromatographic determination of Rifampicin in plasma and tissues. J Chromatogr A 1031:289–294

Carneiro G, Silva EL, Pacheco LA, de Souza-Fagundes EM, Corrêa NC, de Goes AM et al (2012) Formation of ion pairing as an alternative to improve encapsulation and anticancer activity of all-trans retinoic acid loaded in solid lipid nanoparticles. Int J Nanomed 7:6011–6020

Deol P, Khuller GK (1997) Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim Biophys Acta 1334:161–172

Elfinger M, Maucksch C, Rudolph C (2007) Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells. Biomaterials 28:3448–3455

Fry DW (1978) Rapid separation of low molecular weight solutes from liposomes without dilution. J Anal Biochem 90:803–807

Gupta Y, Jain A, Jain SK (2007) Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol 59:1–6

Ito F, Makino K (2004) Preparation and properties of monodispersed Rifampicin loaded poly(lactide-co-glycolide) microspheres. Colloids Surf B 39:17–21

Jaspart S, Piel G, Delattre L, Evrard B (2005) Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications. Expert Opin Drug Deliv 2(1):75–87

Kar A (2005) Pharmaceutical drug absorption; ultraviolet and absorption methods. New Age International Publishers, India 312

Loira-Pastoriza C, Todoroff J, Vanbever R (2014) Delivery strategies for sustained drug release in the lungs. Adv Drug Deliv Rev 75:81–91

Makino K, Nakajima T, Shikamura M, Ito F, Ando S, Kochi C, Inagawa H, Soma G (2004) Efficient intracellular delivery of Rifampicin to alveolar macrophages using Rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of Rifampicin. Colloids Surf B 36:35–42

Muller RH, Keck CM (2010) Pharmaceutical nanoparticles-from their innovative origin to their future. Int J Pharm 390:1–3

Nassimi M, Schleh C, Lauenstein HD, Hussein R, Hoymann HG, Koch W, Pohlmann G, Krug N, Sewald K, Rittinghausen S, Braun A, Müller-Goymann C (2010) A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm 75(2):107–116

O’Hara P, Hickey AJ (2000) Respirable PLGA microspheres containing Rifampicin for the treatment of tuberculosis: manufacture and characterization. Pharm Res 17:955–961

Pandey R, Khuller GK (2005) Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis 85:227–234

Pandey R, Sharma S, Khuller GK (2005) Oral solid lipid nanoparticle-based anti-tubercular chemotherapy. Tuberculosis (Edinb) 85(5–6):415–420

Sahu PK, Mishra DK, Jain N, Rajoriya V, Jain AK (2014) Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel. Drug Dev Ind Pharm (epub ahead of print)

Schubert MA, Goymann MCC (2003) Solvent injection as a new approach for manufacturing lipid nanoparticles evaluation of the method and process parameters. Eur J Pharm Biopharm 55:125–131

Sharma A, Sharma S, Khuller GK (2004) Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis. J Antimicrob Chemother 54(4):761–766

Shuhendler AJ, Prasad P, Leung M, Rauth AM, Dacosta RS, Wu XY (2012) A novel solid lipid nanoparticle formulation for active targeting to tumor α (v) β (3) integrin receptors reveals cyclic RGD as a double-edged sword. Adv Healthc Mater 1(5):600–608

Tomoda K, Makino K (2007) Effects of lung surfactants on Rifampicin release rate from monodisperse Rifampicin-loaded PLGA microspheres. Colloids Surf B Biointerf 55:115–124

Tomoda K, Kojima S, Kajimoto M, Watanabe D, Nakajima T, Makino K (2005) Effects of pulmonary surfactant system on Rifampicin release from Rifampicin-loaded PLGA microspheres. Colloids Surf B Biointerf 45:1–6

Tsuda H, Sekine K, Fujita K, Ligo M (2002) Cancer prevention by bovine lactoferrin and underlying mechanisms-a review of experimental and clinical studies. Biochem Cell Biol 80:131–136

Wang M, Qin L, Li K, Zhu R, Wang W, Wang S (2012) The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-D-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles. AAPS Pharm Sci Tech 13(4):1348–1354

Wissing SA, Muller RH (2002) Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release 81:225–233

Yang X, Liu Y, Liu C, Zhang N (2012) Biodegradable solid lipid nanoparticle flocculates for pulmonary delivery of insulin. J Biomed Nanotech 8(5):834–842

Zhou H, Zhang Y, Biggs DL, Manning MC, Randolph TW, Christians U, Hybertson BM, Ng K (2005) Microparticle-based lung delivery of INH decreases INH metabolism and targets alveolar macrophages. J Control Rel 107:288–299

Zhuang YG, Xu B, Huang F, Wu JJ, Chen S (2012) Solidlipidnanoparticlesof anticancer drugs against MCF-7 cell line and a murine breast cancer model. Pharmazie 67(11):925–929